|
|
Yale Comprehensive Cancer Center Support Grant
|
3P30CA016359-38S1
|
$117,999
|
$8,260
|
FUCHS, CHARLES
|
YALE UNIVERSITY
|
|
|
Yale Comprehensive Cancer Center Support Grant
|
3P30CA016359-38S2
|
$60,000
|
$4,200
|
FUCHS, CHARLES
|
YALE UNIVERSITY
|
|
|
Yale Comprehensive Cancer Center Support Grant
|
3P30CA016359-38S3
|
$125,625
|
$8,794
|
FUCHS, CHARLES
|
YALE UNIVERSITY
|
|
|
Yale Comprehensive Cancer Center Support Grant
|
3P30CA016359-38S4
|
$200,000
|
$14,000
|
FUCHS, CHARLES
|
YALE UNIVERSITY
|
|
|
Yale Comprehensive Cancer Center Support Grant
|
3P30CA016359-38S5
|
$250,000
|
$17,500
|
FUCHS, CHARLES
|
YALE UNIVERSITY
|
|
|
Yale Comprehensive Cancer Center Support Grant
|
5P30CA016359-38
|
$2,600,006
|
$182,000
|
FUCHS, CHARLES
|
YALE UNIVERSITY
|
|
|
XLF in double-strand break repair and chemo/radiosensitization
|
5R01CA166264-05
|
$307,700
|
$307,700
|
POVIRK, LAWRENCE
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
|
Wiskott-Aldrich syndrome protein (WASp) signaling in the oncogenesis of T cell lymphomas
|
1K08CA218460-01
|
$106,531
|
$53,266
|
MURGA-ZAMALLOA, CARLOS
|
UNIVERSITY OF MICHIGAN
|
|
|
Winship Cancer Institute Cancer Center Support Grant
|
2P30CA138292-09
|
$2,524,399
|
$403,904
|
CURRAN, WALTER
|
EMORY UNIVERSITY
|
|
|
Winship Cancer Institute Cancer Center Support Grant
|
3P30CA138292-09S1
|
$59,999
|
$9,600
|
CURRAN, WALTER
|
EMORY UNIVERSITY
|
|
|
Winship Cancer Institute Cancer Center Support Grant
|
3P30CA138292-09S2
|
$102,081
|
$16,333
|
CURRAN, WALTER
|
EMORY UNIVERSITY
|
|
|
Virus-targeted therapeutic for EBV-Associated Malignancies
|
5R44CA153474-03
|
$519,583
|
$519,583
|
PERRINE, SUSAN
|
PHOENICIA BIOSCIENCES, INC.
|
|
|
Video Informed Consent Tools to Improve Care for Patients With Advanced Pancreatic Cancer
|
5K07CA204201-02
|
$176,231
|
$176,231
|
ENZINGER, ANDREA
|
DANA-FARBER CANCER INST
|
|
|
VDAC Regulation of Warburg Metabolism in Hepatocarcinoma
|
3R01CA184456-02S2
|
$25,857
|
$8,533
|
MALDONADO, EDUARDO
|
MEDICAL UNIVERSITY OF SOUTH CAROLINA
|
|
|
VDAC Regulation of Warburg Metabolism in Hepatocarcinoma
|
5R01CA184456-02
|
$341,981
|
$112,854
|
MALDONADO, EDUARDO
|
MEDICAL UNIVERSITY OF SOUTH CAROLINA
|
|
|
VCU Massey Cancer Center Support Grant
|
2P30CA016059-36
|
$2,164,167
|
$216,417
|
GINDER, GORDON
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
|
VCU Massey Cancer Center Support Grant
|
3P30CA016059-36S1
|
$124,341
|
$12,434
|
GINDER, GORDON
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
|
VCU Massey Cancer Center Support Grant
|
3P30CA016059-36S2
|
$19,990
|
$1,999
|
GINDER, GORDON
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
|
Vaccine and radiation for the therapy of human cancers
|
ZIA BC 010975
|
$465,962
|
$465,962
|
Hodge, James
|
CCR (NCI)
|
|
|
Vaccine and Drug Combination Therapy for Human Cancers
|
ZIA BC 010661
|
$465,962
|
$232,981
|
Hodge, James
|
CCR (NCI)
|
|
|
UW Comprehensive Cancer Center Support
|
3P30CA014520-43S1
|
$125,000
|
$1,250
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
|
UW Comprehensive Cancer Center Support
|
3P30CA014520-43S2
|
$31,772
|
$318
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
|
UW Comprehensive Cancer Center Support
|
5P30CA014520-43
|
$4,288,496
|
$42,885
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
|
Using Stat3 Signaling Profiles to Understand Chemotherapy Resistance in AML
|
5R01CA175026-04
|
$379,294
|
$379,294
|
REDELL, MICHELE
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Using Second Harmonic Generation to Predict Metastatic Outcome in Colon Adenocarcinoma
|
1R21CA208921-01A1
|
$200,807
|
$200,807
|
BROWN, EDWARD
|
UNIVERSITY OF ROCHESTER
|
|
|
Using 18F-EF5 PET to measure hypoxia modulation by Nelfinavir in larynx cancer
|
5R01CA174976-04
|
$393,811
|
$393,811
|
MAITY, AMIT
|
UNIVERSITY OF PENNSYLVANIA
|
|
|
Use of Genetically Engineered T cells Targeting Tumor Stroma to Treat Lung Cancer
|
5R01CA172921-05
|
$357,673
|
$178,837
|
ALBELDA, STEVEN
|
UNIVERSITY OF PENNSYLVANIA
|
|
|
Use of Beta-lapachone for Lung Cancer Chemotherapy
|
5R01CA102792-15
|
$335,140
|
$335,140
|
BOOTHMAN, DAVID
|
UT SOUTHWESTERN MEDICAL CENTER
|
|
|
USC Norris Comprehensive Cancer Center (Core) Grant
|
3P30CA014089-42S1
|
$59,999
|
$4,800
|
Wayne, Alan
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
|
USC Norris Comprehensive Cancer Center (Core) Grant
|
5P30CA014089-42
|
$6,263,488
|
$501,079
|
Wayne, Alan
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
|
UPRCCC/MDACC: Partnership for Excellence in Cancer Research (1 of 2)
|
3U54CA096300-15S1
|
$72,364
|
$11,578
|
LOPEZ-BERESTEIN, GABRIEL
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
|
UPRCCC/MDACC: Partnership for Excellence in Cancer Research (1 of 2)
|
5U54CA096300-15
|
$871,799
|
$139,488
|
LOPEZ-BERESTEIN, GABRIEL
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
|
Unlocking the Therapeutic Potential of Retinoic Acid in Acute Myeloid Leukemia
|
5R21CA202488-02
|
$166,931
|
$166,931
|
SWORDS, RONAN
|
UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
|
|
|
University of Virginia Cancer Center Support Grant
|
2P30CA044579-26
|
$2,574,504
|
$231,705
|
LOUGHRAN, THOMAS
|
UNIVERSITY OF VIRGINIA
|
|
|
University of Virginia Cancer Center Support Grant
|
3P30CA044579-26S1
|
$125,000
|
$11,250
|
LOUGHRAN, THOMAS
|
UNIVERSITY OF VIRGINIA
|
|
|
University of Virginia Cancer Center Support Grant
|
3P30CA044579-26S2
|
$104,087
|
$9,368
|
LOUGHRAN, THOMAS
|
UNIVERSITY OF VIRGINIA
|
|
|
University of Michigan Comprehensive Cancer Center Support Grant
|
3P30CA046592-28S3
|
$6,166,044
|
$493,284
|
FEARON, ERIC
|
UNIVERSITY OF MICHIGAN
|
|
|
University of Michigan Comprehensive Cancer Center Support Grant
|
3P30CA046592-28S4
|
$50,000
|
$4,000
|
FEARON, ERIC
|
UNIVERSITY OF MICHIGAN
|
|
|
University of Michigan Comprehensive Cancer Center Support Grant
|
3P30CA046592-28S5
|
$30,973
|
$2,478
|
FEARON, ERIC
|
UNIVERSITY OF MICHIGAN
|
|
|
UNIVERSITY OF MARYLAND GREENEBAUM CANCER CENTER SUPPORT GRANT
|
3P30CA134274-10S1
|
$124,964
|
$2,499
|
CULLEN, KEVIN
|
UNIVERSITY OF MARYLAND BALTIMORE
|
|
|
UNIVERSITY OF MARYLAND GREENEBAUM CANCER CENTER SUPPORT GRANT
|
3P30CA134274-10S2
|
$629,550
|
$12,591
|
CULLEN, KEVIN
|
UNIVERSITY OF MARYLAND BALTIMORE
|
|
|
UNIVERSITY OF MARYLAND GREENEBAUM CANCER CENTER SUPPORT GRANT
|
5P30CA134274-10
|
$2,266,216
|
$45,324
|
CULLEN, KEVIN
|
UNIVERSITY OF MARYLAND BALTIMORE
|
|
|
University of Kentucky Markey Cancer Center - Cancer Center Support Grant
|
3P30CA177558-05S1
|
$60,000
|
$10,800
|
EVERS, BERNARD
|
UNIVERSITY OF KENTUCKY
|
|
|
University of Kentucky Markey Cancer Center - Cancer Center Support Grant
|
3P30CA177558-05S2
|
$125,000
|
$22,500
|
EVERS, BERNARD
|
UNIVERSITY OF KENTUCKY
|
|
|
University of Kentucky Markey Cancer Center - Cancer Center Support Grant
|
3P30CA177558-05S3
|
$241,905
|
$43,543
|
EVERS, BERNARD
|
UNIVERSITY OF KENTUCKY
|
|
|
University of Kentucky Markey Cancer Center - Cancer Center Support Grant
|
3P30CA177558-05S4
|
$101,773
|
$18,319
|
EVERS, BERNARD
|
UNIVERSITY OF KENTUCKY
|
|
|
University of Kentucky Markey Cancer Center - Cancer Center Support Grant
|
3P30CA177558-05S5
|
$253,858
|
$45,694
|
EVERS, BERNARD
|
UNIVERSITY OF KENTUCKY
|
|
|
University of Kentucky Markey Cancer Center - Cancer Center Support Grant
|
5P30CA177558-05
|
$2,107,000
|
$379,260
|
EVERS, BERNARD
|
UNIVERSITY OF KENTUCKY
|
|
|
University of Colorado Cancer Center Support Grant
|
2P30CA046934-29
|
$3,880,607
|
$698,509
|
THEODORESCU, DAN
|
UNIVERSITY OF COLORADO DENVER
|
|
|
University of Colorado Cancer Center Support Grant
|
3P30CA046934-29S1
|
$3,780
|
$680
|
THEODORESCU, DAN
|
UNIVERSITY OF COLORADO DENVER
|
|
Total relevant funding to Chemotherapy for this search: $317,746,569
|
